Repeat visitors to this site may find it useful to have an overview of changes and updates made since their last visit. Here is where to find that information.
For discussion, view the companion site to this site called our brain tumor cocktails and stories
Checklist for the Newly Diagnosed, available at VirtualTrials.com (posted April 3, 2015)
November 19 ~ The Closer Look at IDH Mutations page was updated with new data from the 2017 SNO conference on the phase 1 trial of AG-120 (ivosidenib).
February 4 ~ Find a summary on the Exploring Strategies for IDH1 Mutated Gliomas page of a new study showing increased sensitivity in IDH1 mutant cells to approved PARP inhibitors
November 26 ~ The Exploring Strategies for IDH Mutated Gliomas page was updated with a section called IDH1-mutant cells are highly vulnerable to NAD+ depletion via pharmacological inhibition of NAMPT
Clinical highlights from the 2016 annual SNO meeting have been summarized on the SNO 2016 Clinical Highlights page. Further insights from the conference will be added separately to pages on this site.
November 20 ~ Astrocytoma Options is launched.